choleragarde
Vaccineexperimental
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jul 1, 2010 (NCT00741637)
Timeline
2010s
- Jan 1, 2010
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- Vibrio choleraeImmunity, active
Vibrio cholerae immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- choleragarde
- choleragarde
- peru 15
- peru-15
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00741637 | Phase 2 | Jul 1, 2010 | International Vaccine Institute, Siriraj Hospital, Vaccine Technologies Inc. |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| International Vaccine Institute | Academic/Hospital | 1 | 1 | 1 | 2010 |
| Siriraj Hospital | Academic/Hospital | 1 | 0 | 1 | 2010 |
| Vaccine Technologies Inc. | For profit | 1 | 0 | 1 | 2010 |
3 organizations
Page 1 / 1